You have entered the IISP: Interactive Information System on Pathogenomics
If you would like to insert information about your research or research group, please click to the following link to download the form. After filling it out, please send back to firstname.lastname@example.org or email@example.com.
Here you will find information about Research groups in the PathoGenoMics fields from the ERA-NET partner countries (Austria, Finland, France, Hungary, Israel, Latvia, Portugal, Slovenia and Spain).
This information is supposed to support cooperation between researchers from different European countries
and thus enhance the development of a European Research Area for PathoGenoMics .
The following information is available and can be searched for:
- researcher names
- Institution of the respective researcher, city and country of his/her institution
- Contact data of the researcher (address, phone, email)
- Research topics and studied microorganisms of the researcher
- Special techniques applied by the researcher
- Potential cooperation topics suggested by the researcher
If you have any comments/questions or if you would like to add some information, please contact firstname.lastname@example.org
|Name:||Prof. Dr. Miczák, András|
|Institution:||University of Szeged, Medical School, Dept. Med. Microbiol. Immunobiol.|
|Genes important for intracellular survival and reactivation of mycobacteria and Chlamydophila pneumoniae Our research interests focus on the genetic mechanisms utilized by mycobacteria and chlamydiae to promote their intracellular survival and reactivation within the eukaryotic host. Mycobacteria maintain their vacuoles as non-acidic compartments that do not fuse with lysosomes. These bacteria require the regulated expression of a set of genes to maintain a persistent infection. We would like to study some of these genes. Their products could be possible targets for drug development. The role of RNase E in the regulation of RNA metabolism, SmpB and trans-translation and in general, the connection of bacterial metabolism and pathogenecity will also be studied.|
|Special methods / technologies:|
|Expression and purification proteins from M. bovis BCG|
|Suggestions for potential research cooperations:|